Akzo Nobel India Ltd, CCL Products (India) Ltd, AU Small Finance Bank Ltd, Tata Coffee Ltd are among the other stocks to see a surge in volumes on NSE today, 31 August 2021.

Indoco Remedies Ltd clocked volume of 34.4 lakh shares by 14:19 IST on NSE, a 10.83 times surge over two-week average daily volume of 3.18 lakh shares. The stock gained 3.80% to Rs.484.05. Volumes stood at 5.1 lakh shares in the last session.

Akzo Nobel India Ltd recorded volume of 56987 shares by 14:19 IST on NSE, a 6.14 times surge over two-week average daily volume of 9280 shares. The stock lost 0.14% to Rs.2,205.00. Volumes stood at 11393 shares in the last session.

CCL Products (India) Ltd witnessed volume of 28.33 lakh shares by 14:19 IST on NSE, a 5.87 times surge over two-week average daily volume of 4.83 lakh shares. The stock increased 2.76% to Rs.402.55. Volumes stood at 4.12 lakh shares in the last session.

AU Small Finance Bank Ltd witnessed volume of 74.65 lakh shares by 14:19 IST on NSE, a 5.27 times surge over two-week average daily volume of 14.16 lakh shares. The stock dropped 17.98% to Rs.1,062.05. Volumes stood at 23.42 lakh shares in the last session.

Tata Coffee Ltd registered volume of 144.6 lakh shares by 14:19 IST on NSE, a 5.21 fold spurt over two-week average daily volume of 27.76 lakh shares. The stock rose 6.76% to Rs.212.40. Volumes stood at 16.41 lakh shares in the last session.

Powered by Capital Market - Live News

Action Construction Equipment Ltd, Tata Coffee Ltd, Brigade Enterprises Ltd and Indian Energy Exchange Ltd are among the other gainers in the BSE's 'A' group today, 31 August 2021.

Indoco Remedies Ltd surged 8.52% to Rs 505.7 at 11:50 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 59170 shares were traded on the counter so far as against the average daily volumes of 45245 shares in the past one month.

Action Construction Equipment Ltd soared 8.40% to Rs 236.8. The stock was the second biggest gainer in 'A' group. On the BSE, 99587 shares were traded on the counter so far as against the average daily volumes of 1.01 lakh shares in the past one month.

Tata Coffee Ltd spiked 7.04% to Rs 213. The stock was the third biggest gainer in 'A' group. On the BSE, 10.29 lakh shares were traded on the counter so far as against the average daily volumes of 3.22 lakh shares in the past one month.

Brigade Enterprises Ltd spurt 6.55% to Rs 332.75. The stock was the fourth biggest gainer in 'A' group. On the BSE, 32367 shares were traded on the counter so far as against the average daily volumes of 26003 shares in the past one month.

Indian Energy Exchange Ltd advanced 6.15% to Rs 509.9. The stock was the fifth biggest gainer in 'A' group. On the BSE, 8.24 lakh shares were traded on the counter so far as against the average daily volumes of 2.28 lakh shares in the past one month.

Powered by Capital Market - Live News

Indoco said the virtual inspection was carried out from 4-7 May and 10-11 May 2021. The inspection covered all the phases of bioequivalence studies and was conducted successfully.

Aditi Kare Panandikar, MD of Indoco Remedies said, This is an exciting step in our journey of excellence and a validation of our adherence to delivering quality services to our customers worldwide.

Hyderabad-based AnaCipher CRO is a USFDA inspected clinical research facility and is spread over 30,000 sq. ft area with 98 beds. The facility conducts bioequivalence and bioavailability (BA/BE) studies.

Indoco Remedies, headquartered in Mumbai, is a fully integrated, research-oriented pharma company with presence in 55 countries. On a consolidated basis, the company reported a 132% rise in net profit to Rs 39.66 crore on a 43% rise in net sales to Rs 381.43 crore in Q1 FY22 over Q1 FY21.

Powered by Capital Market - Live News

Indoco Remedies announced today, the receipt of GCP & GLP Accreditation from the UK-MHRA (Medicines and Healthcare Products Regulatory Agency) for its Clinical Research Organisation - AnaCipher, located at Hyderabad for the virtual inspection carried out from 4 - 7 May and 10 - 11 May 2021. The inspection covered all the phases of Bioequivalence studies and was conducted successfully.

Powered by Capital Market - Live News